Nippon Shinyaku Co., Ltd. Profile Avatar - Palmy Investing

Nippon Shinyaku Co., Ltd.

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation a…

Drug Manufacturers - Specialty & Generic
JP, Kyoto [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio -25.64 4.40 5.92
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -201.35 -14.38 -4.77
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 2.42 3269.59 3192.29
Cash 4.38 1020.01 977.16
Capex -845.39 -76.92 -8.14
Free Cash Flow 728.29 44.27 -5.35
Revenue -9.86 527.46 585.18
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 1.53 0.67 0.66
Operating Margin -73.07 0.07 0.26
ROA -77.78 < 0.005 0.03
ROE -76.95 < 0.005 0.04
ROIC -79.26 < 0.005 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 4516.T is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 4516.T is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 4516.T is permitted for members.
End of 4516.T's Analysis
CIK: - CUSIP: - ISIN: JP3717600005 LEI: - UEI: -
Secondary Listings
4516.T has no secondary listings inside our databases.